abnormalities at the diagnosis of MM are of great clinical significance in predicting patient response to therapy and survival. Further, 1q21 and FGFR3 mutations could potentially be used in combination with
status, to better predict patient survival and guide for selecting high-risk patients to advance patient treatment strategies.
TP53 abnormalities at the diagnosis of MM are of great clinical significance in predicting patient response to therapy and survival. Further, 1q21 and FGFR3 mutations could potentially be used in combination with TP53 status, to better predict patient survival and guide for selecting high-risk patients to advance patient treatment strategies.Collecting and reporting data is a crucial aspect of IVF practice. During the following two decades after the first report of European IVF-monitoring Consortium (EIM) on IVF data, the number of contributing countries increased gradually reaching nearly fourty. In 2004 for the first time Turkey took part in European registry and accordingly in World registry. Starting the submission of Turkish data to EIM was an important milestone since Turkey appeared as the sixth country in relation to the number of cycles performing nearly eight percent of all European ART cycles. Turkey continued contributing to European registry for the following four years consecutively but after 2008 the input of Turkish IVF data stopped again. Strikingly, between 2004-2008 Turkey became one of the main contributors of the registry with an ability to give a full report. So far, we do not have a complete European set of data and the number of cycles reported by ESHRE EIM can easily be said to be an underestimation of the actual number of cycles. The IVF data of Turkey - a country having the seventeenth highest population in the World and appearing among the first six countries in Europe in terms of the number of ART cycles per year- will definitely contribute very much to ESHRE EIM database. Then, it is time to turn the tide and restart submitting the data to European registry, but this time regularly in a systematic method. Such an achievement will greatly contribute to the aim of EIM of achieving a complete data set.
Measles vaccinations have been suggested to provide immune protection and decreased measles incidence. However, there was a limited study evaluating how the measles vaccine elicits specific immune responses.
This study aimed to evaluate both humoral and cellular immunity to first-dose measles vaccine Edmonston-Zagreb (EZ) in 9-month-old Indonesian infants.
A cohort study was conducted on 9-month-old infants who got the first-dose of measles vaccine EZ. Measles-specific immunoglobulin G (IgG) antibody serum levels were measured using plaque-reduction microneutralization assay. Peripheral blood mononuclear cells were stimulated with a measles-specific peptide to identify a cellular immune response. Quantification of CD4
and CD8
T-cells producing interferon-gamma (IFN-ɣ) and interleukin 17-A (IL-17A) were conducted by flow cytometry. Humoral and cellular immune response parameters were analyzed over time.
The prevalence of seropositivity rates was 85.8% at 1-month after vaccination and 16.67% at 6-months postvaccination. Measles-specific IgG antibodies increased significantly at 1-month after measles vaccination. However, they decreased significantly 6-months after vaccination. IFN-ɣ and IL-17A secreting T-cells increased significantly at 1-month after measles vaccination. Interestingly, a significant decrease of IFN-ɣ and IL-17A secreting CD4
T cells was noticed 6-months postvaccination compared to IFN-ɣ and IL-17A secreting CD8
T cells.
Our study suggests that the first-dose measles vaccine on 9-months-old infants seems to induce both humoral and cellular immune responses that decline 6-months after vaccination.
Our study suggests that the first-dose measles vaccine on 9-months-old infants seems to induce both humoral and cellular immune responses that decline 6-months after vaccination.
The oral food challenge (OFC) in IgE mediated food allergy causes anxiety both in parents and in patients due to its inherent risks.
Documentation of the rate, spectrum, and predictors of positive reactions is instructive.
Children, who underwent OFC between January 1, 2017 and December 31, 2019 were analyzed.
A total of 1361 OFCs in 613 cases were reviewed. Most of them were performed in preschool children (≤2 years 50%) and 55% of them had more than one OFC. find more Mainly considered food groups were cow's milk (31.8%), hen's egg (28.5%), tree nuts (20%), legumes (7%), seeds (4.9%), and wheat (2.7%). The overall OFC positivity was 9.6%, whereas 6.7% with cow's milk, 4.9% with hen's egg, 16.1% with tree nuts, 21.6% with wheat, and 32.8% with seeds. The severity scoring revealed grade I (24.4%), II (45.8%), and III (29.7%) reactions. Fifty (38%) cases required epinephrine and four cases required hospitalization. OFCs with sesame seeds (odds ratio [OR] 7.747, [confidence interval (CI) 95% 4.03-14.90]), wheat (OR 3.80, [CI 1.64-8.84]), and tree nuts (OR 2.78, [CI 1.83-4.23]) predicted a positive OFC while a concomitant asthma (OR 3.61 [CI 1.27-10.28]) was more likely to elicit anaphylaxis.
In OFC practice, priority is given to basic nutritional sources and the most frequent food allergens, where preschool children with multiple sensitizations are the primary subjects. Increased risks of positive reactions with sesame, tree nut, and wheat and increased risk of anaphylaxis with concomitant asthma should be considered while performing OFC.
In OFC practice, priority is given to basic nutritional sources and the most frequent food allergens, where preschool children with multiple sensitizations are the primary subjects. Increased risks of positive reactions with sesame, tree nut, and wheat and increased risk of anaphylaxis with concomitant asthma should be considered while performing OFC.The post-viral acute cough is the most common symptom in childhood. Consequently, the use of cough relievers is frequent. Many products for treating cough contain natural components. An ancient tradition has always established herbal medicine and honey as effective and safe means to relieve cough. Nevertheless, very few studies adequately investigated the real effectiveness and safety of natural products in treating acute cough. There is some evidence, provided by pediatric randomized controlled trials, about honey, one multicomponent product (containing Plantagolanceolata, Grindelia robusta, Helichrysum italicum, and honey), and Pelargonium sidoides. Other group of substances, including glycerol and isolated natural compounds, can help manage cough but robust evidence still lacks in children. There is an urgent need to perform rigorous studies that confirm the natural products' efficacy and safety for relieving post-viral acute cough.Key points Acute post-viral cough is prevalent in childhood and adolescence.find more
Top comments (0)